A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer. uri icon

authors

  • Yuan, Yuan
  • Reining, Lauren
  • Highlander, Sarah K
  • Robinson, Kim
  • Padam, Simran
  • Martinez, Norma
  • Tang, Aileen
  • Schmolze, Daniel
  • Waisman, James
  • Mina S. Sedrak, MD, MS
  • Lee, Peter P
  • Lee, Jin Sun
  • Mortimer, Joanne
  • Yost, Susan E
  • Frankel, Paul H
  • Ruel, Christopher
  • Egelston, Colt A
  • Guo, Weihua
  • Gillece, John D
  • Folkerts, Megan

publication date

  • January 1, 2020